Logo
x

Search

Subscribe Now

Study

Regeneron Reports Results of REGEN-COV (casirivimab and imdevimab) in P-III Study Against COVID-19

Regeneron Reports Results of REGEN-COV (casirivimab and imdevimab) in P-III Study Against COVID-19

  • November 9, 2021
Amgen Reports Results of Aimovig (erenumab-aooe) in P-lV Study for the Treatment of Episodic and Chronic Migraine

Amgen Reports Results of Aimovig (erenumab-aooe) in P-lV Study for the Treatment of Episodic and Chronic Migraine

  • November 9, 2021
uniQure Provides Positive Recommendation to Advance P- I/II Study of AMT-130 for Huntington Disease

uniQure Provides Positive Recommendation to Advance P- I/II Study of AMT-130 for Huntington Disease

  • November 3, 2021
Biocad Presents Results of BCD-021 (biosimilar, bevacizumab) in P-III Study for the Treatment of NSCLC at ESMO 2021

Biocad Presents Results of BCD-021 (biosimilar, bevacizumab) in P-III Study for the Treatment of NSCLC at ESMO 2021

  • October 27, 2021
Novartis Reports Results of Canakinumab in P-III CANOPY-1 Study for the Treatment of Lung Cancer

Novartis Reports Results of Canakinumab in P-III CANOPY-1 Study for the Treatment of Lung Cancer

  • October 25, 2021
Dicerna Reports Results of Nedosiran in PHYOX4 Study for the Treatment of Primary Hyperoxaluria Type 3

Dicerna Reports Results of Nedosiran in PHYOX4 Study for the Treatment of Primary Hyperoxaluria Type 3

  • October 20, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.